AbbVie (WBO:ABBV) Interest Expense : €-2,601 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is AbbVie Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. AbbVie's interest expense for the three months ended in Dec. 2024 was € -670 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-2,601 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. AbbVie's Operating Income for the three months ended in Dec. 2024 was € 80 Mil. AbbVie's Interest Expense for the three months ended in Dec. 2024 was € -670 Mil. AbbVie's Interest Coverage for the quarter that ended in Dec. 2024 was 0.12. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

AbbVie Interest Expense Historical Data

The historical data trend for AbbVie's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Interest Expense Chart

AbbVie Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-2,017.19

-2,144.36

-2,105.12

-2,039.41

-2,681.64

AbbVie Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-517.19	-607.20	-674.45	-648.72	-670.41

AbbVie Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2,601 Mil.

AbbVie (WBO:ABBV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

AbbVie's Interest Expense for the three months ended in Dec. 2024 was €-670 Mil. Its Operating Income for the three months ended in Dec. 2024 was €80 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €57,625 Mil.

AbbVie's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	80.22	/	-670.41
	=	0.12

The higher the ratio, the stronger the company's financial strength is.

AbbVie Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV34:Brazil 4AB:Bulgaria ABBV:Argentina

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

https://www.abbvie.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).